Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

ELS vs NUVB

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
ELS
Equity LifeStyle Properties, Inc.

REIT - Residential

Real EstateNYSE • US
Market Cap$12.28B
5Y Perf.-4.5%
NUVB
Nuvation Bio Inc.

Biotechnology

HealthcareNYSE • US
Market Cap$1.75B
5Y Perf.-49.6%

ELS vs NUVB — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
ELS logoELS
NUVB logoNUVB
IndustryREIT - ResidentialBiotechnology
Market Cap$12.28B$1.75B
Revenue (TTM)$1.53B$143M
Net Income (TTM)$387M$-146M
Gross Margin37.6%91.6%
Operating Margin33.8%-105.0%
Forward P/E31.1x
Total Debt$3.37B$10M
Cash & Equiv.$26M$164M

ELS vs NUVBLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

ELS
NUVB
StockAug 20May 26Return
Equity LifeStyle Pr… (ELS)10095.5-4.5%
Nuvation Bio Inc. (NUVB)10050.4-49.6%

Price return only. Dividends and distributions are not included.

Quick Verdict: ELS vs NUVB

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: ELS leads in 4 of 6 categories, making it the strongest pick for profitability and margin quality and capital preservation and lower volatility. Nuvation Bio Inc. is the stronger pick specifically for growth and revenue expansion and recent price momentum and sentiment. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
ELS
Equity LifeStyle Properties, Inc.
The Real Estate Income Play

ELS carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.

  • Dividend streak 12 yrs, beta 0.02, yield 3.2%
  • 112.2% 10Y total return vs NUVB's -49.6%
  • Lower volatility, beta 0.02, current ratio 1.68x
Best for: income & stability and long-term compounding
NUVB
Nuvation Bio Inc.
The Growth Play

NUVB is the clearest fit if your priority is growth exposure.

  • Rev growth 7.0%, EPS growth 71.6%
  • 7.0% revenue growth vs ELS's 6.8%
  • +141.1% vs ELS's +2.6%
Best for: growth exposure
See the full category breakdown
CategoryWinnerWhy
GrowthNUVB logoNUVB7.0% revenue growth vs ELS's 6.8%
Quality / MarginsELS logoELS25.2% margin vs NUVB's -102.1%
Stability / SafetyELS logoELSBeta 0.02 vs NUVB's 2.04
DividendsELS logoELS3.2% yield; 12-year raise streak; the other pay no meaningful dividend
Momentum (1Y)NUVB logoNUVB+141.1% vs ELS's +2.6%
Efficiency (ROA)ELS logoELS6.8% ROA vs NUVB's -23.8%, ROIC 7.6% vs -54.3%

ELS vs NUVB — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

ELSEquity LifeStyle Properties, Inc.
FY 2025
Home Sales, Brokered Resales And Ancillary Services
100.0%$86M
NUVBNuvation Bio Inc.
FY 2025
License
60.8%$38M
Product
39.2%$25M

ELS vs NUVB — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLELSLAGGINGNUVB

Income & Cash Flow (Last 12 Months)

Evenly matched — ELS and NUVB each lead in 3 of 6 comparable metrics.

ELS is the larger business by revenue, generating $1.5B annually — 10.7x NUVB's $143M. ELS is the more profitable business, keeping 25.2% of every revenue dollar as net income compared to NUVB's -102.1%. On growth, NUVB holds the edge at +26.0% YoY revenue growth, suggesting stronger near-term business momentum.

MetricELS logoELSEquity LifeStyle …NUVB logoNUVBNuvation Bio Inc.
RevenueTrailing 12 months$1.5B$143M
EBITDAEarnings before interest/tax$727M-$145M
Net IncomeAfter-tax profit$387M-$146M
Free Cash FlowCash after capex$334M-$126M
Gross MarginGross profit ÷ Revenue+37.6%+91.6%
Operating MarginEBIT ÷ Revenue+33.8%-105.0%
Net MarginNet income ÷ Revenue+25.2%-102.1%
FCF MarginFCF ÷ Revenue+21.8%-88.1%
Rev. Growth (YoY)Latest quarter vs prior year+22.4%+26.0%
EPS Growth (YoY)Latest quarter vs prior year-8.3%+106.3%
Evenly matched — ELS and NUVB each lead in 3 of 6 comparable metrics.

Valuation Metrics

NUVB leads this category, winning 2 of 3 comparable metrics.
MetricELS logoELSEquity LifeStyle …NUVB logoNUVBNuvation Bio Inc.
Market CapShares × price$12.3B$1.7B
Enterprise ValueMkt cap + debt − cash$15.6B$1.6B
Trailing P/EPrice ÷ TTM EPS32.81x-8.40x
Forward P/EPrice ÷ next-FY EPS est.31.12x
PEG RatioP/E ÷ EPS growth rate3.17x
EV / EBITDAEnterprise value multiple21.49x
Price / SalesMarket cap ÷ Revenue8.02x27.82x
Price / BookPrice ÷ Book value/share6.98x5.63x
Price / FCFMarket cap ÷ FCF36.76x
NUVB leads this category, winning 2 of 3 comparable metrics.

Profitability & Efficiency

ELS leads this category, winning 6 of 9 comparable metrics.

ELS delivers a 21.3% return on equity — every $100 of shareholder capital generates $21 in annual profit, vs $-44 for NUVB. NUVB carries lower financial leverage with a 0.03x debt-to-equity ratio, signaling a more conservative balance sheet compared to ELS's 1.85x. On the Piotroski fundamental quality scale (0–9), ELS scores 6/9 vs NUVB's 4/9, reflecting solid financial health.

MetricELS logoELSEquity LifeStyle …NUVB logoNUVBNuvation Bio Inc.
ROE (TTM)Return on equity+21.3%-44.1%
ROA (TTM)Return on assets+6.8%-23.8%
ROICReturn on invested capital+7.6%-54.3%
ROCEReturn on capital employed+9.7%-42.8%
Piotroski ScoreFundamental quality 0–964
Debt / EquityFinancial leverage1.85x0.03x
Net DebtTotal debt minus cash$3.3B-$154M
Cash & Equiv.Liquid assets$26M$164M
Total DebtShort + long-term debt$3.4B$10M
Interest CoverageEBIT ÷ Interest expense2.98x-162.11x
ELS leads this category, winning 6 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

Evenly matched — ELS and NUVB each lead in 3 of 6 comparable metrics.

A $10,000 investment in ELS five years ago would be worth $10,412 today (with dividends reinvested), compared to $4,574 for NUVB. Over the past 12 months, NUVB leads with a +141.1% total return vs ELS's +2.6%. The 3-year compound annual growth rate (CAGR) favors NUVB at 46.0% vs ELS's 0.1% — a key indicator of consistent wealth creation.

MetricELS logoELSEquity LifeStyle …NUVB logoNUVBNuvation Bio Inc.
YTD ReturnYear-to-date+6.8%-41.3%
1-Year ReturnPast 12 months+2.6%+141.1%
3-Year ReturnCumulative with dividends+0.2%+211.1%
5-Year ReturnCumulative with dividends+4.1%-54.3%
10-Year ReturnCumulative with dividends+112.2%-49.6%
CAGR (3Y)Annualised 3-year return+0.1%+46.0%
Evenly matched — ELS and NUVB each lead in 3 of 6 comparable metrics.

Risk & Volatility

ELS leads this category, winning 2 of 2 comparable metrics.

ELS is the less volatile stock with a 0.02 beta — it tends to amplify market swings less than NUVB's 2.04 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ELS currently trades 91.8% from its 52-week high vs NUVB's 51.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricELS logoELSEquity LifeStyle …NUVB logoNUVBNuvation Bio Inc.
Beta (5Y)Sensitivity to S&P 5000.02x2.04x
52-Week HighHighest price in past year$69.00$9.75
52-Week LowLowest price in past year$58.15$1.57
% of 52W HighCurrent price vs 52-week peak+91.8%+51.7%
RSI (14)Momentum oscillator 0–10041.054.0
Avg Volume (50D)Average daily shares traded1.7M4.3M
ELS leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

Insufficient data to determine a leader in this category.

Wall Street rates ELS as "Buy" and NUVB as "Buy". Consensus price targets imply 146.0% upside for NUVB (target: $12) vs 11.4% for ELS (target: $71). ELS is the only dividend payer here at 3.20% yield — a key consideration for income-focused portfolios.

MetricELS logoELSEquity LifeStyle …NUVB logoNUVBNuvation Bio Inc.
Analyst RatingConsensus buy/hold/sellBuyBuy
Price TargetConsensus 12-month target$70.57$12.40
# AnalystsCovering analysts219
Dividend YieldAnnual dividend ÷ price+3.2%
Dividend StreakConsecutive years of raises12
Dividend / ShareAnnual DPS$2.02
Buyback YieldShare repurchases ÷ mkt cap0.0%0.0%
Insufficient data to determine a leader in this category.
Key Takeaway

ELS leads in 2 of 6 categories (Profitability & Efficiency, Risk & Volatility). NUVB leads in 1 (Valuation Metrics). 2 tied.

Best OverallEquity LifeStyle Properties… (ELS)Leads 2 of 6 categories
Loading custom metrics...

ELS vs NUVB: Frequently Asked Questions

9 questions · data-driven answers · updated daily

01

Is ELS or NUVB a better buy right now?

For growth investors, Nuvation Bio Inc.

(NUVB) is the stronger pick with 699. 0% revenue growth year-over-year, versus 6. 8% for Equity LifeStyle Properties, Inc. (ELS). Equity LifeStyle Properties, Inc. (ELS) offers the better valuation at 32. 8x trailing P/E (31. 1x forward), making it the more compelling value choice. Analysts rate Equity LifeStyle Properties, Inc. (ELS) a "Buy" — based on 21 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which is the better long-term investment — ELS or NUVB?

Over the past 5 years, Equity LifeStyle Properties, Inc.

(ELS) delivered a total return of +4. 1%, compared to -54. 3% for Nuvation Bio Inc. (NUVB). Over 10 years, the gap is even starker: ELS returned +112. 2% versus NUVB's -49. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

03

Which is safer — ELS or NUVB?

By beta (market sensitivity over 5 years), Equity LifeStyle Properties, Inc.

(ELS) is the lower-risk stock at 0. 02β versus Nuvation Bio Inc. 's 2. 04β — meaning NUVB is approximately 9648% more volatile than ELS relative to the S&P 500. On balance sheet safety, Nuvation Bio Inc. (NUVB) carries a lower debt/equity ratio of 3% versus 185% for Equity LifeStyle Properties, Inc. — giving it more financial flexibility in a downturn.

04

Which is growing faster — ELS or NUVB?

By revenue growth (latest reported year), Nuvation Bio Inc.

(NUVB) is pulling ahead at 699. 0% versus 6. 8% for Equity LifeStyle Properties, Inc. (ELS). On earnings-per-share growth, the picture is similar: Nuvation Bio Inc. grew EPS 71. 6% year-over-year, compared to -1. 5% for Equity LifeStyle Properties, Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

05

Which has better profit margins — ELS or NUVB?

Equity LifeStyle Properties, Inc.

(ELS) is the more profitable company, earning 25. 2% net margin versus -325. 3% for Nuvation Bio Inc. — meaning it keeps 25. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ELS leads at 33. 8% versus -338. 7% for NUVB. At the gross margin level — before operating expenses — NUVB leads at 86. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

06

Is ELS or NUVB more undervalued right now?

Analyst consensus price targets imply the most upside for NUVB: 146.

0% to $12. 40.

07

Which pays a better dividend — ELS or NUVB?

In this comparison, ELS (3.

2% yield) pays a dividend. NUVB does not pay a meaningful dividend and should not be held primarily for income.

08

Is ELS or NUVB better for a retirement portfolio?

For long-horizon retirement investors, Equity LifeStyle Properties, Inc.

(ELS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 02), 3. 2% yield, +112. 2% 10Y return). Nuvation Bio Inc. (NUVB) carries a higher beta of 2. 04 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (ELS: +112. 2%, NUVB: -49. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

09

What are the main differences between ELS and NUVB?

These companies operate in different sectors (ELS (Real Estate) and NUVB (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: ELS is a mid-cap income-oriented stock; NUVB is a small-cap high-growth stock. ELS pays a dividend while NUVB does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

ELS

High-Growth Quality Leader

  • Sector: Real Estate
  • Market Cap > $100B
  • Revenue Growth > 11%
  • Net Margin > 15%
Run This Screen
Stocks Like

NUVB

High-Growth Disruptor

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 1299%
  • Gross Margin > 54%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform ELS and NUVB on the metrics below

Revenue Growth>
%
(ELS: 22.4% · NUVB: 2598.7%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.